Compile Data Set for Download or QSAR
Report error Found 290 Enz. Inhib. hit(s) with all data for entry = 10467
TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537769(US11248001, Example 176 | US11603523, Example 176)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537768(US11248001, Example 175 | US11603523, Example 175)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537773(US11248001, Example 180 | US11603523, Example 180)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537775(US11248001, Example 182 | US11603523, Example 182)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537774(US11248001, Example 181 | US11603523, Example 181)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537745(US11248001, Example 95 | US11603523, Example 95)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537744(US11248001, Example 94 | US11603523, Example 94)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537746(US11248001, Example 96 | US11603523, Example 96)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537754(US11248001, Example 105 | US11603523, Example 105)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537793(US11248001, Example 212 | US11603523, Example 212)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537798(US11248001, Example 217 | US11603523, Example 217)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537805(US11248001, Example 224 | US11603523, Example 224)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537804(US11248001, Example 223 | US11603523, Example 223)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537777(US11248001, Example 184 | US11603523, Example 184)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537776(US11248001, Example 183 | US11603523, Example 183)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537781(US11248001, Example 188 | US11603523, Example 188)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537784(US11248001, Example 203 | US11603523, Example 203)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537787(US11248001, Example 206 | US11603523, Example 206)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537788(US11248001, Example 207 | US11603523, Example 207)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537825(US11248001, Example 250 | US11603523, Example 368)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537827(US11248001, Example 302 | US11603523, Example 302)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537835(US11248001, Example 310)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537837(US11248001, Example 312 | US11603523, Example 312)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537836(US11248001, Example 311 | US11603523, Example 311)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537839(US11248001, Example 314 | US11603523, Example 314)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537838(US11248001, Example 313 | US11603523, Example 313)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537811(US11248001, Example 230 | US11603523, Example 230)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537815(US11248001, Example 240 | US11603523, Example 240)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537816(US11248001, Example 241 | US11603523, Example 241)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537818(US11248001, Example 243)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537821(US11248001, Example 246 | US11603523, Example 246)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537820(US11248001, Example 245 | US11603523, Example 245)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537823(US11248001, Example 248)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537822(US11248001, Example 247 | US11603523, Example 247)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537857(US11248001, Example 332 | US11603523, Example 332)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537856(US11248001, Example 331 | US11603523, Example 331)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537859(US11248001, Example 334 | US11603523, Example 334)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537858(US11248001, Example 333 | US11603523, Example 333)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537861(US11248001, Example 336 | US11603523, Example 336)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537860(US11248001, Example 335 | US11603523, Example 335)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537863(US11248001, Example 338)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537862(US11248001, Example 337 | US11603523, Example 337)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537865(US11248001, Example 340 | US11603523, Example 340)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537864(US11248001, Example 339 | US11603523, Example 339)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537867(US11248001, Example 342 | US11603523, Example 342)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537866(US11248001, Example 341 | US11603523, Example 341)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537868(US11248001, Example 343 | US11603523, Example 343)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537871(US11248001, Example 346 | US11603523, Example 346)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537870(US11248001, Example 345 | US11603523, Example 345)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetProprotein convertase subtilisin/kexin type 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM537840(US11248001, Example 315 | US11603523, Example 315)
Affinity DataKd: <200nMAssay Description:Surface plasmon resonance data was collected on a Biacore T200 or 3000 system (GE Healthcare) at 25° C. Streptavidin was immobilized on a CMS (GE Hea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

Displayed 1 to 50 (of 290 total ) | Next | Last >>
Jump to: